methotrexate [Ligand Id: 4815] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL34259 (Abitrexate, ADX-2191, Amethopterin, CL 14377, CL-14377, D-amethopterin, D-methotrexate, Ebetrex, EMT-25299, Emtexate high-pot, Emtexate pf, Folex, Jylamvo, Maxtrex, Methotrexate, Methotrexate, d-, Methotrexate, (r)-, Methotrexatum, Methylaminopterin, Metoject, Mexate, Mexate-AQ, Nordimet, NSC-740, Otrexup, Otrexup pfs, R-9985, Rasuvo, Reditrex, Rheumatrex, (r)-methotrexate, R-methotrexate, TCMDC-123832, TCMDC-125488, TCMDC-125858, Trexall, Zlatal) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| AICAR transformylase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2518] [UniProtKB: P31939] | ||||||||
| ChEMBL | Inhibition of human full length N-terminal His-tagged ATIC expressed in Chinese Hamster MTXRII-OuaR2-4 R2 cells assessed as reduction in THF formation using 10-CHOTHF as substrate by spectrophotometric method | B | 6.06 | pKi | 880 | nM | Ki | Bioorg Med Chem (2021) 37: 116093-116093 [PMID:33773393] |
| ChEMBL | Inhibitory activity against AICAR formyltransferase of Lactobacillus casei | B | 4.7 | pIC50 | >20000 | nM | IC50 | J Med Chem (1988) 31: 150-153 [PMID:3121855] |
| Bifunctional dihydrofolate reductase-thymidylate synthase in Trypanosoma cruzi (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1163130] [UniProtKB: Q27793] | ||||||||
| ChEMBL | Inhibition of Trypanosoma cruzi DHFR-TS in presence of NADPH by spectrophotometry | B | 6.96 | pIC50 | 110 | nM | IC50 | Bioorg Med Chem (2022) 58: 116577-116577 [PMID:35189560] |
| ABCC3/Canalicular multispecific organic anion transporter 2 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2073682] [GtoPdb: 781] [UniProtKB: O88563] | ||||||||
| ChEMBL | TP_TRANSPORTER: inhibition of E217betaG uptake in membrane vesicles from Mrp3-expressing Sf9 cells | F | 4.05 | pKi | 90000 | nM | Ki | Pharm Res (2002) 19: 34-41 [PMID:11837698] |
| Dihydrofolate reductase in Escherichia coli (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1809] [UniProtKB: P0ABQ4] | ||||||||
| ChEMBL | Thermodynamic Dissociation Constant for compound-Tyr31-dihydrofolate reductase (DHFR) complex at pH 9.5 | B | 5.77 | pKd | 1700 | nM | Kd | J Med Chem (1988) 31: 129-137 [PMID:3275776] |
| ChEMBL | Thermodynamic Dissociation Constant for compound-Val31-dihydrofolate reductase (DHFR) complex at pH 9.5 | B | 5.96 | pKd | 1100 | nM | Kd | J Med Chem (1988) 31: 129-137 [PMID:3275776] |
| ChEMBL | Thermodynamic Dissociation Constant for compound-Tyr31-dihydrofolate reductase (DHFR) complex at pH 8 | B | 6.85 | pKd | 140 | nM | Kd | J Med Chem (1988) 31: 129-137 [PMID:3275776] |
| ChEMBL | Thermodynamic Dissociation Constant for compound-Val31-dihydrofolate reductase (DHFR) complex at pH 8 | B | 7.08 | pKd | 84 | nM | Kd | J Med Chem (1988) 31: 129-137 [PMID:3275776] |
| ChEMBL | Thermodynamic Dissociation Constant for compound-Phe31-dihydrofolate reductase (DHFR) complex at pH 9.5 | B | 7.51 | pKd | 31 | nM | Kd | J Med Chem (1988) 31: 129-137 [PMID:3275776] |
| ChEMBL | Thermodynamic Dissociation Constant for compound-Val31-dihydrofolate reductase (DHFR) complex at pH 6 | B | 8.49 | pKd | 3.2 | nM | Kd | J Med Chem (1988) 31: 129-137 [PMID:3275776] |
| ChEMBL | Thermodynamic Dissociation Constant for compound-Tyr31-dihydrofolate reductase (DHFR) complex at pH 6 | B | 8.64 | pKd | 2.3 | nM | Kd | J Med Chem (1988) 31: 129-137 [PMID:3275776] |
| ChEMBL | Inhibitory activity against dihydrofolate reductase | B | 9 | pKd | <1 | nM | Kd | Bioorg Med Chem Lett (2004) 14: 2285-2289 [PMID:15081026] |
| ChEMBL | Thermodynamic Dissociation Constant for compound-Phe31-dihydrofolate reductase (DHFR) complex at pH 8 | B | 10.02 | pKd | 0.1 | nM | Kd | J Med Chem (1988) 31: 129-137 [PMID:3275776] |
| ChEMBL | Thermodynamic Dissociation Constant for compound-Phe31-dihydrofolate reductase (DHFR) complex at pH 6 | B | 10.64 | pKd | 0.02 | nM | Kd | J Med Chem (1988) 31: 129-137 [PMID:3275776] |
| ChEMBL | Binding constant(Ki) to dihydrofolate reductase (DHFR) Tyr -31 was determined | B | 5.62 | pKi | 2400 | nM | Ki | J Med Chem (1988) 31: 129-137 [PMID:3275776] |
| ChEMBL | Binding constant(Ki) to dihydrofolate reductase (DHFR) Phe -31 was determined | B | 6.48 | pKi | 330 | nM | Ki | J Med Chem (1988) 31: 129-137 [PMID:3275776] |
| ChEMBL | Binding affinity against Dihydrofolate reductase of Escherichia coli | B | 10.68 | pKi | 0.02 | nM | Ki | J Med Chem (1985) 28: 303-311 [PMID:3973902] |
| ChEMBL | Inhibitory activity against recombinant Escherichia coli dihydrofolate reductase | B | 5.36 | pIC50 | 4400 | nM | IC50 | J Med Chem (2001) 44: 1993-2003 [PMID:11384244] |
| ChEMBL | Inhibition of Escherichia coli DHFR | B | 7.49 | pIC50 | 32 | nM | IC50 | J Med Chem (2004) 47: 6730-6739 [PMID:15615522] |
| ChEMBL | Inhibition of Escherichia coli dihydrofolate reductase (DHFR) | B | 8.05 | pIC50 | 9 | nM | IC50 | J Med Chem (2002) 45: 1942-1948 [PMID:11960504] |
| ChEMBL | Inhibitory concentration against Escherichia coli Dihydrofolate reductase | B | 8.05 | pIC50 | 9 | nM | IC50 | J Med Chem (2000) 43: 3125-3133 [PMID:10956221] |
| ChEMBL | Inhibition of Escherichia coli DHFR | B | 8.06 | pIC50 | 8.8 | nM | IC50 | J Med Chem (2008) 51: 5789-5797 [PMID:18800768] |
| ChEMBL | Inhibition of Escherichia coli DHFR | B | 8.06 | pIC50 | 8.8 | nM | IC50 | Bioorg Med Chem (2012) 20: 4217-4225 [PMID:22739090] |
| ChEMBL | Inhibition of Escherichia coli dihydrofolate reductase | B | 8.06 | pIC50 | 8.8 | nM | IC50 | J Med Chem (2009) 52: 4892-4902 [PMID:19719239] |
| ChEMBL | Inhibition of Escherichia coli DHFR | B | 8.15 | pIC50 | 7 | nM | IC50 | J Med Chem (2004) 47: 6893-6901 [PMID:15615538] |
| ChEMBL | Inhibition of Escherichia coli dihydrofolate reductase at 37 degree C pH 7.4 | B | 8.15 | pIC50 | 7 | nM | IC50 | J Med Chem (2005) 48: 5329-5336 [PMID:16078850] |
| ChEMBL | Compound was evaluated as inhibitor of Escherichia coli Dihydrofolate reductase | B | 8.15 | pIC50 | 7 | nM | IC50 | J Med Chem (2003) 46: 591-600 [PMID:12570380] |
| ChEMBL | Inhibition of Escherichia coli DHFR | B | 8.18 | pIC50 | 6.6 | nM | IC50 | J Med Chem (2005) 48: 7215-7222 [PMID:16279780] |
| ChEMBL | Inhibition of Escherichia coli DHFR at 30 degC under pH 7.4 by spectrophotometry | B | 8.18 | pIC50 | 6.6 | nM | IC50 | Bioorg Med Chem (2010) 18: 953-961 [PMID:20056546] |
| ChEMBL | Inhibition of Escherichia coli DHFR | B | 8.18 | pIC50 | 6.6 | nM | IC50 | J Med Chem (2010) 53: 1563-1578 [PMID:20092323] |
| ChEMBL | Inhibition of Escherichia coli dihydrofolate reductase | B | 8.18 | pIC50 | 6.6 | nM | IC50 | J Med Chem (2008) 51: 4589-4600 [PMID:18605720] |
| ChEMBL | Inhibitory activity against Escherichia coli (ec) Dihydrofolate reductase | B | 8.22 | pIC50 | 6 | nM | IC50 | J Med Chem (2002) 45: 5173-5181 [PMID:12408727] |
| ChEMBL | Inhibitory concentration against isolated Escherichia coli Dihydrofolate reductase | B | 8.22 | pIC50 | 6 | nM | IC50 | J Med Chem (2000) 43: 3837-3851 [PMID:11052789] |
| ChEMBL | Inhibition of Escherichia coli DHFR by spectrophotometry | B | 8.36 | pIC50 | 4.4 | nM | IC50 | Bioorg Med Chem (2011) 19: 3585-3594 [PMID:21550809] |
| ChEMBL | Inhibition of Escherichia coli DHFR | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (2006) 49: 6977-6986 [PMID:17125251] |
| ChEMBL | Inhibitory activity against recombinant ec dihydrofolate reductase(in 50 uM dihydrofolic acid) | B | 8.66 | pIC50 | 2.2 | nM | IC50 | J Med Chem (1996) 39: 1438-1446 [PMID:8691474] |
| Dihydrofolate reductase in S.aureus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1681620] [UniProtKB: P0A017] | ||||||||
| ChEMBL | Inhibition of Staphylococcus aureus DHFR | B | 9 | pKi | 1 | nM | Ki | ACS Med Chem Lett (2016) 7: 692-696 [PMID:27437079] |
| Dihydrofolate reductase in Enterococcus faecium (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3243913] [UniProtKB: P00380] | ||||||||
| ChEMBL | Inhibition of Streptococcus faecium dihydrofolate reductase using dihydrofolate as substrate | B | 8.85 | pIC50 | 1.4 | nM | IC50 | J Med Chem (1977) 20: 588-591 [PMID:850245] |
| Dihydrofolate reductase in Bacillus anthracis (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5270] [UniProtKB: Q81R22] | ||||||||
| ChEMBL | Inhibition of Bacillus anthracis DHFR | B | 7.82 | pIC50 | 15 | nM | IC50 | Antimicrob Agents Chemother (2009) 53: 3065-3073 [PMID:19364848] |
| ChEMBL | Inhibition of Bacillus anthracis DHFR | B | 7.91 | pIC50 | 12.2 | nM | IC50 | Antimicrob Agents Chemother (2009) 53: 3065-3073 [PMID:19364848] |
| Dihydrofolate reductase in Lactobacillus casei (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2902] [UniProtKB: P00381] | ||||||||
| ChEMBL | Inhibitory activity against recombinant lc dihydrofolate reductase(in 50 uM dihydrofolic acid) | B | 7.26 | pIC50 | 55 | nM | IC50 | J Med Chem (1996) 39: 1438-1446 [PMID:8691474] |
| ChEMBL | Inhibitory concentration against isolated Lactobacillus casei Dihydrofolate reductase | B | 7.36 | pIC50 | 44 | nM | IC50 | J Med Chem (2000) 43: 3837-3851 [PMID:11052789] |
| ChEMBL | Inhibitory activity against dihydrofolate reductase in Lactobacillus casei was determined (glutamate residue 2) | F | 7.59 | pIC50 | 26 | nM | IC50 | J Med Chem (1988) 31: 181-185 [PMID:2447278] |
| ChEMBL | Compound was evaluated as inhibitor of Lactobacillus casei Dihydrofolate reductase | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2003) 46: 591-600 [PMID:12570380] |
| ChEMBL | Inhibition of Lactobacillus casei DHFR | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2004) 47: 6893-6901 [PMID:15615538] |
| ChEMBL | Inhibition of Lactobacillus casei dihydrofolate reductase at 37 degree C pH 7.4 | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2005) 48: 5329-5336 [PMID:16078850] |
| ChEMBL | Inhibitory activity against dihydrofolate reductase in Lactobacillus casei was determined (glutamate residue 6) | F | 7.8 | pIC50 | 16 | nM | IC50 | J Med Chem (1988) 31: 181-185 [PMID:2447278] |
| ChEMBL | Inhibitory activity against dihydrofolate reductase in Lactobacillus casei was determined (glutamate residue 3) | F | 7.8 | pIC50 | 16 | nM | IC50 | J Med Chem (1988) 31: 181-185 [PMID:2447278] |
| ChEMBL | Evaluated for inhibition of dihydrofolate reductase (DHFR) from Lactobacillus casei | B | 7.8 | pIC50 | 16 | nM | IC50 | J Med Chem (1988) 31: 2164-2169 [PMID:3184124] |
| ChEMBL | Inhibitory activity against dihydrofolate reductase in Lactobacillus casei was determined (glutamate residue 2) | F | 7.8 | pIC50 | 16 | nM | IC50 | J Med Chem (1988) 31: 181-185 [PMID:2447278] |
| ChEMBL | Inhibitory activity against dihydrofolate reductase of Lactobacillus casei | B | 7.8 | pIC50 | 16 | nM | IC50 | J Med Chem (1988) 31: 150-153 [PMID:3121855] |
| ChEMBL | Inhibitory activity against dihydrofolate reductase in Lactobacillus casei was determined (glutamate residue 5) | F | 7.82 | pIC50 | 15 | nM | IC50 | J Med Chem (1988) 31: 181-185 [PMID:2447278] |
| ChEMBL | Inhibitory activity against dihydrofolate reductase in Lactobacillus casei was determined (glutamate residue 4) | F | 7.82 | pIC50 | 15 | nM | IC50 | J Med Chem (1988) 31: 181-185 [PMID:2447278] |
| ChEMBL | In vitro inhibition of Dihydrofolate reductase activity against Lactobacillus casei enzyme | F | 7.92 | pIC50 | 12 | nM | IC50 | J Med Chem (1982) 25: 877-880 [PMID:7108907] |
| ChEMBL | Inhibitory concentration against Lactobacillus casei Dihydrofolate reductase | B | 7.96 | pIC50 | 11 | nM | IC50 | J Med Chem (2000) 43: 3125-3133 [PMID:10956221] |
| ChEMBL | Compound was evaluated for the inhibition of dihydrofolate reductase (DHFR) derived from Lactobacillus casei ATCC 7469 | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (1986) 29: 1056-1061 [PMID:3712374] |
| ChEMBL | Compound was evaluated for the inhibition of dihydrofolate reductase (DHFR)derived from Lactobacillus casei | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (1986) 29: 1786-1789 [PMID:3091834] |
| ChEMBL | Ability to inhibit Lactobacillus casei dihydrofolate reductase in vitro was determined | B | 8.02 | pIC50 | 9.6 | nM | IC50 | J Med Chem (1980) 23: 899-903 [PMID:6772788] |
| ChEMBL | Inhibitory activity against dihydrofolate reductase of Lactobacillus casei | B | 8.07 | pIC50 | 8.5 | nM | IC50 | J Med Chem (1986) 29: 1754-1760 [PMID:3091832] |
| ChEMBL | Concentration required for 50% inhibition against dihydrofolate reductase of Lactobacillus casei | B | 8.1 | pIC50 | 8 | nM | IC50 | J Med Chem (1983) 26: 605-607 [PMID:6403710] |
| ChEMBL | Inhibitory activity against dihydrofolate reductase derived from Lactobacillus casei | B | 8.1 | pIC50 | 8 | nM | IC50 | J Med Chem (1986) 29: 1263-1269 [PMID:3100797] |
| ChEMBL | inhibitory concentration against Lactobacillus casei DHFR(Dihydro folate reductase). | B | 8.22 | pIC50 | 6 | nM | IC50 | J Med Chem (1995) 38: 3798-3805 [PMID:7562910] |
| ChEMBL | Inhibitory concentration for DHFR in Lactobacillus casei | B | 8.22 | pIC50 | 6 | nM | IC50 | J Med Chem (1994) 37: 1169-1176 [PMID:8164259] |
| ChEMBL | Inhibition of Lactobacillus casei DHFR | B | 8.22 | pIC50 | 6 | nM | IC50 | J Med Chem (2007) 50: 3283-3289 [PMID:17569517] |
| ChEMBL | Inhibition of Lactobacillus casei DHFR by spectrophotometric analysis | B | 8.3 | pIC50 | 5 | nM | IC50 | Bioorg Med Chem (2010) 18: 5081-5089 [PMID:20580561] |
| ChEMBL | Inhibition of DCM-resistant Lactobacillus casei DHFR | B | 8.35 | pIC50 | 4.5 | nM | IC50 | J Med Chem (1976) 19: 825-829 [PMID:820858] |
| ChEMBL | Inhibition of MTX-resistant Lactobacillus casei dihydrofolate reductase | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (1977) 20: 1323-1327 [PMID:409842] |
| ChEMBL | Inhibition of Lactobacillus casei ATCC 7469 dihydrofolate reductase | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (1979) 22: 869-874 [PMID:109616] |
| ChEMBL | Inhibitory activity against recombinant sf dihydrofolate reductase(in 50 uM dihydrofolic acid) | B | 8.66 | pIC50 | 2.2 | nM | IC50 | J Med Chem (1996) 39: 1438-1446 [PMID:8691474] |
| ChEMBL | Compound was tested for the inhibition of dihydrofolate reductase in Bovine liver | B | 8.89 | pIC50 | 1.3 | nM | IC50 | J Med Chem (1994) 37: 1616-1624 [PMID:8201595] |
| Dihydrofolate reductase in Mycobacterium tuberculosis (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6065] [UniProtKB: P9WNX1] | ||||||||
| ChEMBL | Inhibition of Mycobacterium tuberculosis His-tagged DHFR assessed as reduction in consumption of NADPH using DHF as substrate measured every 30 secs over 6 mins by spectrophotometric method | B | 7.46 | pIC50 | 35 | nM | IC50 | Eur J Med Chem (2018) 144: 262-276 [PMID:29274493] |
| ChEMBL | Inhibition of Mycobacterium tuberculosis H37Rv DHFR expressed in Escherichia coli BL21(DE3) assessed as reduction in consumption of NADPH using DHF as substrate preincubated for 1 min followed by DHF addition and measured for 2 mins by spectrophotometric method | B | 8.06 | pIC50 | 8.8 | nM | IC50 | Bioorg Med Chem (2019) 27: 1421-1429 [PMID:30827867] |
| ChEMBL | Inhibition of recombinant Mycobacterium tuberculosis DHFR using 45 uM DHF as substrate by spectrophotometry | B | 8.08 | pIC50 | 8.25 | nM | IC50 | ACS Med Chem Lett (2015) 6: 1140-1144 [PMID:26617968] |
| Dihydrofolate reductase in Pneumocystis carinii (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1926] [UniProtKB: P16184] | ||||||||
| ChEMBL | Inhibitory activity was determined against dihydrofolate reductase in Pneumocystis carinii. | B | 6.06 | pIC50 | 880 | nM | IC50 | J Med Chem (1995) 38: 4739-4759 [PMID:7490723] |
| ChEMBL | Inhibitory concentration against isolated Pneumocystis carinii DHFR (Dihydrofolate reductase) | B | 7.86 | pIC50 | 13.8 | nM | IC50 | J Med Chem (2000) 43: 3837-3851 [PMID:11052789] |
| ChEMBL | Inhibitory activity against dihydrofolate reductase in Pneumocystis carinii at 37 centigrade. | B | 8.89 | pIC50 | 1.3 | nM | IC50 | J Med Chem (1995) 38: 4739-4759 [PMID:7490723] |
| ChEMBL | Inhibitory activity against Dihydrofolate reductase from Pneumocystis carinii was evaluated using 90 uM dihydrofolic acid as substrate | B | 8.89 | pIC50 | 1.3 | nM | IC50 | J Med Chem (1997) 40: 3040-3048 [PMID:9301666] |
| ChEMBL | Inhibitory activity against Pneumocystis carinii dihydrofolate reductase (in 90 uM dihydrofolic acid) | B | 8.89 | pIC50 | 1.3 | nM | IC50 | J Med Chem (1996) 39: 1438-1446 [PMID:8691474] |
| ChEMBL | Inhibition of Pneumocystis carinii DHFR | B | 8.89 | pIC50 | 1.3 | nM | IC50 | J Med Chem (2013) 56: 4422-4441 [PMID:23627352] |
| ChEMBL | Inhibitory activity against pneumocystis carinii Dihydrofolate reductase | B | 8.96 | pIC50 | 1.1 | nM | IC50 | J Med Chem (2002) 45: 5173-5181 [PMID:12408727] |
| ChEMBL | Inhibition of Pneumocystis carinii (pc) Dihydrofolate reductase | B | 9 | pIC50 | 1 | nM | IC50 | J Med Chem (1995) 38: 2158-2165 [PMID:7783147] |
| ChEMBL | Inhibition against Dihydrofolate reductase in Pneumocystis carinii | B | 9 | pIC50 | 1 | nM | IC50 | J Med Chem (1997) 40: 1173-1177 [PMID:9089339] |
| ChEMBL | Inhibition of Pneumocystis carinii dihydrofolate reductase | B | 9 | pIC50 | 1 | nM | IC50 | J Med Chem (1998) 41: 1409-1416 [PMID:9554874] |
| ChEMBL | Inhibitory concentration for DHFR in Pneumocystis carinii | B | 9 | pIC50 | 1 | nM | IC50 | J Med Chem (1994) 37: 1169-1176 [PMID:8164259] |
| Dihydrofolate reductase in Leishmania major (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4614] [UniProtKB: P07382] | ||||||||
| ChEMBL | Inhibition of dihydrofolate reductase (DHFR) from Leishmania major | B | 9.89 | pKi | 0.13 | nM | Ki | J Med Chem (1987) 30: 1218-1224 [PMID:3599028] |
| Dihydrofolate reductase in Toxoplasma gondii (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2425] [UniProtKB: Q07422] | ||||||||
| ChEMBL | Inhibition of Toxoplasma gondii TS assessed as oxidation of tetrahydrofolate to dihydrofolate after 2 to 12 mins by spectrophotometry | B | 4.74 | pIC50 | >18000 | nM | IC50 | Bioorg Med Chem (2011) 19: 3585-3594 [PMID:21550809] |
| ChEMBL | Inhibition of Toxoplasma gondii TS at 30 degC under pH 7.4 by spectrophotometry | B | 4.74 | pIC50 | 18000 | nM | IC50 | Bioorg Med Chem (2010) 18: 953-961 [PMID:20056546] |
| ChEMBL | Inhibition of Toxoplasma gondii thymidylate synthase | B | 4.74 | pIC50 | 18000 | nM | IC50 | J Med Chem (2008) 51: 4589-4600 [PMID:18605720] |
| ChEMBL | Inhibition of Toxoplasma gondii thymidylate synthase | B | 4.74 | pIC50 | 18000 | nM | IC50 | J Med Chem (2005) 48: 7215-7222 [PMID:16279780] |
| ChEMBL | Inhibition of Toxoplasma gondii DHFR-TS | B | 4.85 | pIC50 | 14000 | nM | IC50 | J Med Chem (2007) 50: 940-950 [PMID:17269758] |
| ChEMBL | Inhibitory activity against Toxoplasma gondii dihydrofolate reductase | B | 5.96 | pIC50 | 1100 | nM | IC50 | J Med Chem (2001) 44: 1993-2003 [PMID:11384244] |
| ChEMBL | Inhibition of Toxoplasma gondii DHFR-TS expressed in Escherichia coli BL21 competent cells using DHF as substrate preincubated for 15 mins followed by substrate and NADPH addition and measured after 60 mins by resazurin dye based diaphorase-coupled assay | B | 7.11 | pIC50 | 78.3 | nM | IC50 | J Med Chem (2019) 62: 1562-1576 [PMID:30624926] |
| ChEMBL | Inhibition of Toxoplasma gondii TS-DHFR expressed in Escherichia coli BL21 preincubated for 15 mins followed by addition of DHF as substrate and NADPH measured after 60 mins by resazurin/diaphorase coupled assay | B | 7.15 | pIC50 | 71 | nM | IC50 | ACS Med Chem Lett (2016) 7: 1124-1129 [PMID:27994750] |
| ChEMBL | Inhibition of Toxoplasma gondii dihydrofolate reductase | B | 7.48 | pIC50 | 33 | nM | IC50 | J Med Chem (2009) 52: 4892-4902 [PMID:19719239] |
| ChEMBL | Inhibition of Toxoplasma gondii DHFR | B | 7.48 | pIC50 | 33 | nM | IC50 | J Med Chem (2008) 51: 5789-5797 [PMID:18800768] |
| ChEMBL | Inhibition of Toxoplasma gondii DHFR | B | 7.48 | pIC50 | 33 | nM | IC50 | Bioorg Med Chem (2012) 20: 4217-4225 [PMID:22739090] |
| ChEMBL | Inhibitory activity against Toxoplasma gondii (tg) Dihydrofolate reductase (DHFR) | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2002) 45: 5173-5181 [PMID:12408727] |
| ChEMBL | Inhibitory activity against Toxoplasma gondii dihydrofolate reductase (in 50 uM dihydrofolic acid) | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (1996) 39: 1438-1446 [PMID:8691474] |
| ChEMBL | Inhibitory concentration against isolated Toxoplasma gondii DHFR (dihydrofolate reductase) | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2000) 43: 3837-3851 [PMID:11052789] |
| ChEMBL | Inhibitory concentration against Toxoplasma gondii Dihydrofolate reductase | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2000) 43: 3125-3133 [PMID:10956221] |
| ChEMBL | Inhibition of Toxoplasma gondii DHFR by spectrophotometry | B | 7.66 | pIC50 | 22 | nM | IC50 | Bioorg Med Chem (2011) 19: 3585-3594 [PMID:21550809] |
| ChEMBL | Inhibitory concentration for DHFR in Toxoplasma gondii | B | 7.85 | pIC50 | 14 | nM | IC50 | J Med Chem (1994) 37: 1169-1176 [PMID:8164259] |
| ChEMBL | Inhibitory activity against Toxoplasma gondii dihydrofolate reductase (in 90 uM dihydrofolic acid) | B | 7.85 | pIC50 | 14 | nM | IC50 | J Med Chem (1996) 39: 1438-1446 [PMID:8691474] |
| ChEMBL | Inhibition of Toxoplasma gondii Dihydrofolate reductase | B | 7.85 | pIC50 | 14 | nM | IC50 | J Med Chem (1998) 41: 1409-1416 [PMID:9554874] |
| ChEMBL | Inhibition of Toxoplasma gondii (tc) Dihydrofolate reductase | B | 7.85 | pIC50 | 14 | nM | IC50 | J Med Chem (1995) 38: 2158-2165 [PMID:7783147] |
| ChEMBL | Inhibition against Dihydrofolate reductase in Toxoplasma gondii | B | 7.85 | pIC50 | 14 | nM | IC50 | J Med Chem (1997) 40: 1173-1177 [PMID:9089339] |
| ChEMBL | Inhibition of Toxoplasma gondii DHFR | B | 7.96 | pIC50 | 11 | nM | IC50 | J Med Chem (2005) 48: 7215-7222 [PMID:16279780] |
| ChEMBL | Inhibition of Toxoplasma gondii dihydrofolate reductase | B | 7.96 | pIC50 | 11 | nM | IC50 | J Med Chem (2008) 51: 4589-4600 [PMID:18605720] |
| ChEMBL | Inhibition of Toxoplasma gondii DHFR at 30 degC under pH 7.4 by spectrophotometry | B | 7.96 | pIC50 | 11 | nM | IC50 | Bioorg Med Chem (2010) 18: 953-961 [PMID:20056546] |
| ChEMBL | Inhibition of Toxoplasma gondii dihydrofolate reductase (DHFR) | B | 7.96 | pIC50 | 11 | nM | IC50 | J Med Chem (2002) 45: 1942-1948 [PMID:11960504] |
| ChEMBL | Inhibitory activity against Dihydrofolate reductase from Toxoplasma gondii was evaluated using 90 uM dihydrofolic acid as substrate | B | 8.85 | pIC50 | 1.4 | nM | IC50 | J Med Chem (1997) 40: 3040-3048 [PMID:9301666] |
| Dihydrofolate reductase in Plasmodium falciparum K1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1939] [UniProtKB: P13922] | ||||||||
| ChEMBL | Inhibition of Plasmodium falciparum DHFR | B | 7.08 | pIC50 | 84 | nM | IC50 | Bioorg Med Chem (2017) 25: 6467-6478 [PMID:29111368] |
| Dihydrofolate reductase in Chicken (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2575] [UniProtKB: P00378] | ||||||||
| ChEMBL | Evaluated for the inhibition of chicken liver Dihydrofolate reductase by using standard enzyme assay | B | 7.05 | pIC50 | 90 | nM | IC50 | J Med Chem (1982) 25: 475-477 [PMID:7069726] |
| ChEMBL | Compound was evaluated for the inhibition of dihydrofolate reductase (DHFR) derived from Chicken liver | B | 7.72 | pIC50 | 19 | nM | IC50 | J Med Chem (1986) 29: 1056-1061 [PMID:3712374] |
| dihydrofolate reductase/Dihydrofolate reductase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL202] [GtoPdb: 2603] [UniProtKB: P00374] | ||||||||
| ChEMBL | Binding affinity against Dihydrofolate reductase | B | 9.71 | pKd | -9.71 | - | Log Kd | J Med Chem (2002) 45: 2770-2780 [PMID:12061879] |
| ChEMBL | Inhibition of human dihydrofolate reductase | B | 5.35 | pKi | 4420 | nM | Ki | Eur J Med Chem (2008) 43: 189-203 [PMID:17532099] |
| GtoPdb | - | - | 8.92 | pKi | 1.2 | nM | Ki | J Med Chem (1995) 38: 745-52 [PMID:7877140] |
| ChEMBL | Inhibitory activity against dihydrofolate reductase in humans | B | 9.75 | pKi | 0.18 | nM | Ki | Bioorg Med Chem Lett (1999) 9: 1463-1468 [PMID:10360757] |
| ChEMBL | Inhibitory activity against Leu22-Phe mutant human Dihydrofolate reductase | B | 9.96 | pKi | 0.11 | nM | Ki | J Med Chem (1995) 38: 745-752 [PMID:7877140] |
| ChEMBL | Inhibition of human DHFR in presence of variable DHFA level by enzyme kinetics assay | B | 10.11 | pKi | 0.08 | nM | Ki | Bioorg Med Chem (2009) 17: 7324-7336 [PMID:19748785] |
| ChEMBL | Inhibitory activity against Trypanosoma cruzi dihydrofolate reductase | B | 10.42 | pKi | 0.04 | nM | Ki | Bioorg Med Chem Lett (1999) 9: 1463-1468 [PMID:10360757] |
| ChEMBL | Inhibition of DHFR (unknown origin) | B | 11 | pKi | 0.01 | nM | Ki | Eur J Med Chem (2017) 135: 467-478 [PMID:28477572] |
| ChEMBL | Inhibition of human DHFR assessed as conversion of dihydrofolic acid to tetrahydrfolic acid by enzyme immunoassay in presence of NADPH | B | 5.82 | pIC50 | 1500 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 1936-1940 [PMID:26979156] |
| ChEMBL | Inhibition of human dihydrofolate reductase using dihydrofolic acid as substrate preincubated for 1 hr in presence of NADPH followed by substrate addition by enzyme immunoassay | B | 6 | pIC50 | 1000 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 126631-126631 [PMID:31447082] |
| ChEMBL | Inhibitory activity against purified human dihydrofolate reductase (DHFR) in human leukemia cells (CCRF-CEM) | B | 6.14 | pIC50 | 720 | nM | IC50 | J Med Chem (1996) 39: 66-72 [PMID:8568828] |
| ChEMBL | Inhibition of DHFR (unknown origin) incubated for 2 to 5 mins by absorbance based analysis | B | 7.06 | pIC50 | 88 | nM | IC50 | Bioorg Med Chem Lett (2023) 87: 129285-129285 [PMID:37054758] |
| ChEMBL | Inhibition of recombinant human DHFR using dihydrofolate as substrate in presence of NADPH | B | 7.08 | pIC50 | 83 | nM | IC50 | ACS Med Chem Lett (2020) 11: 1421-1428 [PMID:32676149] |
| ChEMBL | Inhibition of human DHFR after 2 mins | B | 7.1 | pIC50 | 80 | nM | IC50 | Bioorg Med Chem (2010) 18: 2849-2863 [PMID:20350811] |
| ChEMBL | Inhibitory activity against human dihydrofolate reductase | B | 7.18 | pIC50 | 66 | nM | IC50 | J Med Chem (2001) 44: 1993-2003 [PMID:11384244] |
| ChEMBL | Inhibition of recombinant human DHFR expressed in Escherichia coli incubated for 15 mins and measured by ELISA | B | 7.21 | pIC50 | 61 | nM | IC50 | Eur J Med Chem (2022) 241: 114661-114661 [PMID:35964425] |
| ChEMBL | Inhibitory concentration against recombinant human DHFR(Dihydro folate reductase). | B | 7.4 | pIC50 | 40 | nM | IC50 | J Med Chem (1995) 38: 3798-3805 [PMID:7562910] |
| ChEMBL | Inhibitory activity against recombinant human dihydrofolate reductase(in 50 uM dihydrofolic acid) | B | 7.42 | pIC50 | 38 | nM | IC50 | J Med Chem (1996) 39: 1438-1446 [PMID:8691474] |
| ChEMBL | Inhibition of DHFR using folic acid substrate | B | 7.46 | pIC50 | 35 | nM | IC50 | Bioorg Med Chem (2007) 15: 1266-1274 [PMID:17127067] |
| ChEMBL | Inhibition of recombinant human DHFR using dihydrofolate as substrate after 15 mins in presence of NADPH | B | 7.46 | pIC50 | 35 | nM | IC50 | Bioorg Med Chem (2018) 26: 2674-2685 [PMID:29691154] |
| ChEMBL | Inhibition of human recombinant DHFR by spectrophotometry | B | 7.48 | pIC50 | 32.94 | nM | IC50 | Eur J Med Chem (2009) 44: 764-771 [PMID:18555562] |
| ChEMBL | Inhibition of recombinant human DHFR using dihydrofolate as substrate after 15 mins in presence of NADPH | B | 7.51 | pIC50 | 30.9 | nM | IC50 | Eur J Med Chem (2017) 128: 88-97 [PMID:28152430] |
| ChEMBL | Inhibitory activity towards dihydrofolate reductase derived from human manca leukemia cells | B | 7.52 | pIC50 | 30 | nM | IC50 | J Med Chem (1990) 33: 212-215 [PMID:2296020] |
| ChEMBL | Tested for inhibition against dihydro folate reductase in Pigeon liver | B | 7.59 | pIC50 | 26 | nM | IC50 | J Med Chem (1980) 23: 320-321 [PMID:7365749] |
| ChEMBL | Ability to inhibit purified Dihydrofolate reductase from human leukemic lymphoblasts was determined spectrophotometrically at 340 nM. | B | 7.6 | pIC50 | 25 | nM | IC50 | J Med Chem (1991) 34: 203-208 [PMID:1992118] |
| ChEMBL | Inhibition of recombinant human DHFR using dihydrofolic acid as substrate in presence of NADPH after 15 mins by microplate reader analysis | B | 7.6 | pIC50 | 24.99 | nM | IC50 | Eur J Med Chem (2019) 178: 329-340 [PMID:31200235] |
| ChEMBL | Inhibition of dihydrofolate reductase (DHFR) from human cells (WI-L2/M4). | B | 7.62 | pIC50 | 24 | nM | IC50 | J Med Chem (1991) 34: 574-579 [PMID:1995880] |
| ChEMBL | Compound was evaluated for Dihydrofolate Reductase (DHFR) inhibition | B | 7.62 | pIC50 | 24 | nM | IC50 | J Med Chem (1991) 34: 227-234 [PMID:1992122] |
| ChEMBL | Inhibition of recombinant human DHFR | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2006) 49: 1055-1065 [PMID:16451071] |
| ChEMBL | Inhibition of human recombinant DHFR | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2004) 47: 6893-6901 [PMID:15615538] |
| ChEMBL | Inhibition of human DHFR | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2005) 48: 7215-7222 [PMID:16279780] |
| ChEMBL | Inhibition of human DHFR | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2007) 50: 3046-3053 [PMID:17552508] |
| ChEMBL | Inhibitory activity against recombinant human Dihydrofolate reductase | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2002) 45: 5173-5181 [PMID:12408727] |
| ChEMBL | Compound was evaluated as inhibitor of human Dihydrofolate reductase | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2003) 46: 591-600 [PMID:12570380] |
| ChEMBL | Inhibition of rh dihydrofolate reductase (DHFR) | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2002) 45: 1942-1948 [PMID:11960504] |
| ChEMBL | Inhibition of human DHFR using dihydrofolate as substrate by spectrophotometric method | B | 7.66 | pIC50 | 22 | nM | IC50 | Bioorg Med Chem Lett (2017) 27: 1602-1607 [PMID:28258797] |
| ChEMBL | Inhibitory concentration against recombinant human (rh) Dihydrofolate reductase | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2000) 43: 3125-3133 [PMID:10956221] |
| ChEMBL | Inhibition of human DHFR at 30 degC under pH 7.4 by spectrophotometry | B | 7.66 | pIC50 | 22 | nM | IC50 | Bioorg Med Chem (2010) 18: 953-961 [PMID:20056546] |
| ChEMBL | Inhibition of human dihydrofolate reductase | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2008) 51: 4589-4600 [PMID:18605720] |
| ChEMBL | Inhibition of human DHFR by spectrophotometry | B | 7.66 | pIC50 | 22 | nM | IC50 | Bioorg Med Chem (2011) 19: 3585-3594 [PMID:21550809] |
| ChEMBL | Inhibition of human DHFR | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2010) 53: 1563-1578 [PMID:20092323] |
| ChEMBL | Inhibition of human dihydrofolate reductase at 37 degree C pH 7.4 | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2005) 48: 5329-5336 [PMID:16078850] |
| ChEMBL | Inhibition of human DHFR | B | 7.7 | pIC50 | 20 | nM | IC50 | Bioorg Med Chem (2012) 20: 4217-4225 [PMID:22739090] |
| ChEMBL | Compound was tested for its inhibitory activity against dihydrofolate reductase (DHFR), isolated from MTX-resistant WI-L2 cells | B | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (1989) 32: 517-520 [PMID:2918496] |
| ChEMBL | Inhibition of DHFR in human KB cells expressing RFC/FRalpha/PCFT assessed as reduction in cell growth after 96 hrs in presence of folic acid by Cell-Titer Blue assay | B | 7.7 | pIC50 | 20 | nM | IC50 | Bioorg Med Chem (2020) 28: 115544-115544 [PMID:32503687] |
| ChEMBL | Inhibition of human recombinant DHFR expressed in Escherichia coli by spectrophotometric analysis | B | 7.7 | pIC50 | 20 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 518-523 [PMID:26670841] |
| ChEMBL | Inhibition of human recombinant dihydrofolate reductase | B | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (2009) 52: 4892-4902 [PMID:19719239] |
| ChEMBL | Inhibition of human recombinant DHFR | B | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (2007) 50: 3283-3289 [PMID:17569517] |
| ChEMBL | Inhibition of human recombinant DHFR | B | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (2008) 51: 68-76 [PMID:18072727] |
| ChEMBL | Inhibition of human recombinant DHFR | B | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (2008) 51: 5789-5797 [PMID:18800768] |
| ChEMBL | Inhibitory concentration against isolated human Dihydrofolate reductase | B | 7.84 | pIC50 | 14.5 | nM | IC50 | J Med Chem (2000) 43: 3837-3851 [PMID:11052789] |
| ChEMBL | Tested for inhibitory concentration against human dihydrofolate reductase(DHFR) | B | 7.95 | pIC50 | 11.2 | nM | IC50 | J Med Chem (1994) 37: 2167-2174 [PMID:8035423] |
| ChEMBL | Inhibition of human DHFR | B | 8.05 | pIC50 | 9 | nM | IC50 | J Med Chem (2004) 47: 6730-6739 [PMID:15615522] |
| ChEMBL | Inhibition of DHFR using dihydrofolic acid substrate | B | 8.05 | pIC50 | 9 | nM | IC50 | Bioorg Med Chem (2007) 15: 1266-1274 [PMID:17127067] |
| ChEMBL | Inhibition of recombinant human DHFR assessed as reduction in conversion of DHF to THF measured every 30 secs for 6 mins by UV-Vis spectrophotometric method | B | 8.1 | pIC50 | 7.9 | nM | IC50 | J Med Chem (2017) 60: 1734-1745 [PMID:28177228] |
| ChEMBL | Ability to inhibit human leukemia cell dihydrofolate reductase in vitro was determined | B | 8.1 | pIC50 | 7.9 | nM | IC50 | J Med Chem (1980) 23: 899-903 [PMID:6772788] |
| ChEMBL | Inhibition of human recombinant dihydrofolate reductase using dihydrofolate as substrate measured every 30 secs over 6 mins by UV/visible spectrophotometer in presence of NADPH | B | 8.1 | pIC50 | 7.9 | nM | IC50 | Eur J Med Chem (2016) 115: 63-74 [PMID:26994844] |
| ChEMBL | Inhibition of recombinant human DHFR assessed as reduction in consumption of NADPH using DHF as substrate measured every 30 secs over 6 mins by spectrophotometric method | B | 8.15 | pIC50 | 7.1 | nM | IC50 | Eur J Med Chem (2018) 144: 262-276 [PMID:29274493] |
| ChEMBL | Inhibition of recombinant human DHFR using DHF as substrate measured every 5 sec over 6 mins in presence of NADPH by UV-Visible spectrophotometric method relative to control | B | 8.18 | pIC50 | 6.67 | nM | IC50 | Eur J Med Chem (2017) 125: 1279-1288 [PMID:27886545] |
| ChEMBL | Inhibition of DHFR in human KB cells expressing RFC/FRalpha/PCFT assessed as reduction in cell growth after 96 hrs by Cell-Titer Blue assay | B | 8.22 | pIC50 | 6 | nM | IC50 | Bioorg Med Chem (2020) 28: 115544-115544 [PMID:32503687] |
| ChEMBL | Inhibition of human Dihydrofolate reductase by the compound was evaluated. | B | 8.37 | pIC50 | 4.3 | nM | IC50 | J Med Chem (1989) 32: 1559-1565 [PMID:2738891] |
| ChEMBL | Inhibition of human WIL2/dihydrofolate reductase activity | B | 8.37 | pIC50 | 4.3 | nM | IC50 | J Med Chem (1989) 32: 852-856 [PMID:2704031] |
| ChEMBL | Inhibitory concentration for DHFR in recombinant human | B | 8.4 | pIC50 | 4 | nM | IC50 | J Med Chem (1994) 37: 1169-1176 [PMID:8164259] |
| ChEMBL | Compound was tested for its inhibitory activity on Recombinant Human Dihydrofolate Reductase. | B | 8.41 | pIC50 | 3.9 | nM | IC50 | J Med Chem (1991) 34: 222-227 [PMID:1992121] |
| ChEMBL | Inhibitory activity against dihydrofolate reductase (DHFR) obtained from human WIL2 cells | B | 8.42 | pIC50 | 3.8 | nM | IC50 | J Med Chem (1988) 31: 449-454 [PMID:3339615] |
| ChEMBL | Inhibition of human DHFR assessed as depletion of NADPH after 30 secs shaking by spectrophotometry | B | 8.52 | pIC50 | 3 | nM | IC50 | Medchemcomm (2013) 4: 817-821 |
| ChEMBL | Inhibitory activity against dihydrofolate reductase of Streptococcus faecium | B | 8.57 | pIC50 | 2.7 | nM | IC50 | J Med Chem (1986) 29: 1754-1760 [PMID:3091832] |
| ChEMBL | In vitro inhibition of human dihydrofolate reductase (DHFR) | B | 8.57 | pIC50 | 2.7 | nM | IC50 | J Med Chem (1992) 35: 1578-1588 [PMID:1578484] |
| ChEMBL | Inhibition of human dihydrofolate reductase by spectrophotometric analysis | B | 8.68 | pIC50 | 2.1 | nM | IC50 | Eur J Med Chem (2013) 64: 401-409 [PMID:23665106] |
| ChEMBL | Ability to inhibit recombinant human dihydrofolate reductase. | B | 8.7 | pIC50 | 2 | nM | IC50 | J Med Chem (2000) 43: 3852-3861 [PMID:11052790] |
| ChEMBL | Inhibition of human recombinant DHFR | B | 8.77 | pIC50 | 1.7 | nM | IC50 | J Med Chem (2013) 56: 4422-4441 [PMID:23627352] |
| ChEMBL | Inhibition of human DHFR using 45 uM DHF as substrate by spectrophotometry | B | 8.8 | pIC50 | 1.6 | nM | IC50 | ACS Med Chem Lett (2015) 6: 1140-1144 [PMID:26617968] |
| ChEMBL | Inhibition of dihydrofolate reductase (unknown origin) using dihydrofolic acid as substrate by spectrophotometry | B | 8.82 | pIC50 | 1.5 | nM | IC50 | J Med Chem (1979) 22: 741-743 [PMID:110934] |
| ChEMBL | Inhibitory activity against Dihydrofolate reductase (DHFR) isolated from CCRF-CEM human leukemia cells in experiment 2 | B | 8.85 | pIC50 | 1.4 | nM | IC50 | J Med Chem (1996) 39: 56-65 [PMID:8568827] |
| ChEMBL | Concentration required for 50% inhibition against dihydrofolate reductase of Streptococcus faecium | B | 8.92 | pIC50 | 1.2 | nM | IC50 | J Med Chem (1983) 26: 605-607 [PMID:6403710] |
| ChEMBL | Inhibitory activity against Dihydrofolate reductase (DHFR) isolated from CCRF-CEM human leukemia cells in experiment 1 | B | 8.93 | pIC50 | 1.18 | nM | IC50 | J Med Chem (1996) 39: 56-65 [PMID:8568827] |
| ChEMBL | Inhibition of human recombinant DHFR | B | 9 | pIC50 | 1 | nM | IC50 | J Med Chem (2008) 51: 449-469 [PMID:18205293] |
| ChEMBL | Inhibitory concentration against dihydrofolate reductase (DHFR) enzyme isolated from CCRF-CEM human leukemia cells. | B | 9.09 | pIC50 | 0.82 | nM | IC50 | J Med Chem (1996) 39: 2536-2540 [PMID:8691451] |
| ChEMBL | Inhibitory activity against Dihydrofolate reductase (DHFR) isolated from CCRF-CEM human leukemia cells in experiment 1 | B | 9.14 | pIC50 | 0.72 | nM | IC50 | J Med Chem (1996) 39: 56-65 [PMID:8568827] |
| ChEMBL | Inhibitory concentration against CCRF-CEM leukemic cell DHFR(Dihydro folate reductase). | B | 9.15 | pIC50 | 0.7 | nM | IC50 | J Med Chem (1995) 38: 3798-3805 [PMID:7562910] |
| ChEMBL | Inhibitory activity against Dihydrofolate reductase (DHFR) isolated from CCRF-CEM human leukemia cells in experiment 2 | B | 9.22 | pIC50 | 0.6 | nM | IC50 | J Med Chem (1996) 39: 56-65 [PMID:8568827] |
| Dihydrofolate reductase in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075051] [UniProtKB: P00376] | ||||||||
| ChEMBL | Inhibition of bovine DHFR after 2 mins by spectrophotometry | B | 7.1 | pIC50 | 80 | nM | IC50 | Eur J Med Chem (2013) 63: 33-45 [PMID:23454532] |
| ChEMBL | Inhibition of bovine liver DHFR measured for every 1 min of 10 mins | B | 7.1 | pIC50 | 80 | nM | IC50 | Eur J Med Chem (2014) 74: 234-245 [PMID:24469112] |
| ChEMBL | Inhibition of bovine DHFR after 2 mins | B | 7.1 | pIC50 | 80 | nM | IC50 | Bioorg Med Chem (2010) 18: 2849-2863 [PMID:20350811] |
| ChEMBL | Inhibition of bovine liver DHFR measured every 1 min for 10 mins | B | 7.1 | pIC50 | 80 | nM | IC50 | Eur J Med Chem (2013) 66: 135-145 [PMID:23792351] |
| ChEMBL | Inhibition of bovine liver DHFR preincubated for 2 mins followed by addition of FH2 as substrate and NADPH | B | 8.1 | pIC50 | 8 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 4815-4823 [PMID:27554444] |
| ChEMBL | Inhibition of bovine liver DHFR | B | 8.1 | pIC50 | 8 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 4557-4567 [PMID:25139568] |
| ChEMBL | Inhibition of bovine liver DHFR using dihydrofolic acid substrate by UV-visible spectrophotometry | B | 8.47 | pIC50 | 3.4 | nM | IC50 | Bioorg Med Chem (2010) 18: 737-743 [PMID:20036565] |
| ChEMBL | In vitro ability to inhibit the Dihydrofolate reductase extracted from beef liver. | B | 8.48 | pIC50 | 3.3 | nM | IC50 | J Med Chem (1984) 27: 605-609 [PMID:6585550] |
| ChEMBL | In vitro inhibitory concentration against beef liver dihydrofolate reductase | B | 8.77 | pIC50 | 1.7 | nM | IC50 | J Med Chem (1985) 28: 914-921 [PMID:4009615] |
| dihydrofolate reductase/Dihydrofolate reductase in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4564] [GtoPdb: 2603] [UniProtKB: P00375] | ||||||||
| ChEMBL | Binding affinity towards Dihydrofolate reductase derived from L1210 cells using [3H]- MTX as the radioligand | B | 5.41 | pKi | 3900 | nM | Ki | J Med Chem (1990) 33: 212-215 [PMID:2296020] |
| ChEMBL | compound was evaluated for the inhibitory activity against Dihydrofolate reductase in permeabilised L1210 cells. | B | 7.14 | pIC50 | 73 | nM | IC50 | J Med Chem (1996) 39: 4340-4344 [PMID:8863812] |
| ChEMBL | Inhibitory activity towards dihydrofolate reductase in L1210 murine leukemia cell lines | B | 7.3 | pIC50 | 50 | nM | IC50 | J Med Chem (1984) 27: 888-893 [PMID:6737432] |
| ChEMBL | Evaluated for the inhibition of dihydrofolate reductase from L1210 mouse leukemia cells | B | 7.35 | pIC50 | 45 | nM | IC50 | J Med Chem (1985) 28: 209-215 [PMID:3968685] |
| ChEMBL | Compound was tested for its ability to inhibit dihydrofolate reductase purified from murine L1210 cells | B | 7.46 | pIC50 | 35 | nM | IC50 | J Med Chem (1986) 29: 1872-1876 [PMID:2428979] |
| ChEMBL | Compound was tested for its ability to inhibit purified dihydrofolate reductase(DHFR) from L1210/R81 cells | B | 7.46 | pIC50 | 35 | nM | IC50 | J Med Chem (1986) 29: 655-660 [PMID:2871191] |
| ChEMBL | Inhibition of dihydrofolate reductase (DHFR) from mouse cells (L1210/R71). | B | 7.6 | pIC50 | 25 | nM | IC50 | J Med Chem (1991) 34: 574-579 [PMID:1995880] |
| ChEMBL | Inhibition of dihydrofolate reductase (DHFR) from murine leukemia cells | B | 7.6 | pIC50 | 25 | nM | IC50 | J Med Chem (1988) 31: 1332-1337 [PMID:3385730] |
| ChEMBL | Tested for inhibition against purified Dihydrofolate reductase from L1210 murine leukemia cells | B | 7.6 | pIC50 | 25 | nM | IC50 | J Med Chem (1988) 31: 1338-1344 [PMID:2898531] |
| ChEMBL | Inhibition of dihydrofolate reductase(DHFR) from L1210/R81 cells | B | 7.6 | pIC50 | 25 | nM | IC50 | J Med Chem (1987) 30: 1463-1469 [PMID:3112397] |
| ChEMBL | Compound was tested for its inhibitory concentration to inhibit the enzyme Dihydro Folate Reductase (DHFR) from murine L1210 leukemia cells. | B | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (1986) 29: 1703-1709 [PMID:3462394] |
| ChEMBL | Compound was tested for the inhibition of dihydrofolate reductase in P388 cells | B | 8.18 | pIC50 | 6.6 | nM | IC50 | J Med Chem (1994) 37: 1616-1624 [PMID:8201595] |
| dihydrofolate reductase/Dihydrofolate reductase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2363] [GtoPdb: 2603] [UniProtKB: Q920D2] | ||||||||
| ChEMBL | Inhibition of rat liver DHFR by enzyme kinetics assay in presence of variable DHFA level | B | 10.14 | pKi | 0.07 | nM | Ki | Bioorg Med Chem (2009) 17: 7324-7336 [PMID:19748785] |
| ChEMBL | Inhibition of rat liver dihydrofolate reductase assayed spectrophotometrically at 340 nM | B | 8.34 | pIC50 | 4.6 | nM | IC50 | J Med Chem (1985) 28: 209-215 [PMID:3968685] |
| ChEMBL | Inhibition against Dihydrofolate reductase in rat liver | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (1997) 40: 1173-1177 [PMID:9089339] |
| ChEMBL | Inhibition of Dihydrofolate reductase of rat liver | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (1998) 41: 1409-1416 [PMID:9554874] |
| ChEMBL | Inhibitory concentration for DHFR in rat liver | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (1994) 37: 1169-1176 [PMID:8164259] |
| ChEMBL | Inhibition of rat liver Dihydrofolate reductase | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (1995) 38: 2158-2165 [PMID:7783147] |
| ChEMBL | Inhibitory activity against rat liver dihydrofolate reductase (in 90 uM dihydrofolic acid) | B | 8.6 | pIC50 | 2.5 | nM | IC50 | J Med Chem (1996) 39: 1438-1446 [PMID:8691474] |
| ChEMBL | Inhibition of rat liver Dihydrofolate reductase (rlDHFR) | B | 8.6 | pIC50 | 2.5 | nM | IC50 | J Med Chem (2003) 46: 3455-3462 [PMID:12877583] |
| ChEMBL | Inhibitory activity against Dihydrofolate reductase from rat liver was evaluated using 90 uM dihydrofolic acid as substrate | B | 8.6 | pIC50 | 2.5 | nM | IC50 | J Med Chem (1997) 40: 3040-3048 [PMID:9301666] |
| ChEMBL | Inhibition of rat liver DHFR | B | 8.6 | pIC50 | 2.5 | nM | IC50 | J Med Chem (2013) 56: 4422-4441 [PMID:23627352] |
| ChEMBL | Ability to inhibit recombinant rat liver dihydrofolate reductase. | B | 8.7 | pIC50 | 2 | nM | IC50 | J Med Chem (2000) 43: 3852-3861 [PMID:11052790] |
| ChEMBL | Inhibition of rat liver dihydrofolate reductase using dihydrofolate as substrate | B | 9 | pIC50 | <1 | nM | IC50 | J Med Chem (1977) 20: 588-591 [PMID:850245] |
| folate receptor alpha/Folate receptor alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2121] [GtoPdb: 3212] [UniProtKB: P15328] | ||||||||
| ChEMBL | Inhibition of FRalpha (unknown origin) expressed in Chinese hamster RT16 cells assessed as cell growth inhibition incubated up to 96 hrs in presence of 200 nM folic acid by Celltiter-blue cell viability assay | B | 6.34 | pIC50 | 461 | nM | IC50 | J Med Chem (2014) 57: 8152-8166 [PMID:25234128] |
| ChEMBL | Binding affinity to human FR-alpha receptor expressed in Chinese hamster RT16 cells assessed as antiproliferative activity measured as reduction in cell viability after 96 hrs in presence of folic acid by Cell-Titer Blue assay | B | 6.67 | pIC50 | 216 | nM | IC50 | J Med Chem (2018) 61: 2027-2040 [PMID:29425443] |
| ChEMBL | Inhibition of FRalpha (unknown origin) expressed in Chinese hamster RT16 cells assessed as cell growth inhibition incubated up to 96 hrs by Celltiter-blue cell viability assay | B | 6.94 | pIC50 | 114 | nM | IC50 | J Med Chem (2014) 57: 8152-8166 [PMID:25234128] |
| ChEMBL | Binding affinity to human FR-alpha receptor expressed in Chinese hamster RT16 cells assessed as antiproliferative activity measured as reduction in cell viability after 96 hrs by Cell-Titer Blue assay | B | 6.94 | pIC50 | 114 | nM | IC50 | J Med Chem (2018) 61: 2027-2040 [PMID:29425443] |
| Folate receptor beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5064] [UniProtKB: P14207] | ||||||||
| ChEMBL | Inhibition of FRbeta (unknown origin) expressed in Chinese hamster D4 cells assessed as cell growth inhibition incubated up to 96 hrs in presence of 200 nM folic acid by Celltiter-blue cell viability assay | B | 6.68 | pIC50 | 211 | nM | IC50 | J Med Chem (2014) 57: 8152-8166 [PMID:25234128] |
| ChEMBL | Binding affinity to human FR-beta receptor expressed in Chinese hamster D4 cells assessed as antiproliferative activity measured as reduction in cell viability after 96 hrs in presence of folic acid by Cell-Titer Blue assay | B | 6.68 | pIC50 | 211 | nM | IC50 | J Med Chem (2018) 61: 2027-2040 [PMID:29425443] |
| ChEMBL | Inhibition of FRbeta (unknown origin) expressed in Chinese hamster D4 cells assessed as cell growth inhibition incubated up to 96 hrs by Celltiter-blue cell viability assay | B | 6.97 | pIC50 | 106 | nM | IC50 | J Med Chem (2014) 57: 8152-8166 [PMID:25234128] |
| ChEMBL | Binding affinity to human FR-beta receptor expressed in Chinese hamster D4 cells assessed as antiproliferative activity measured as reduction in cell viability after 96 hrs by Cell-Titer Blue assay | B | 6.97 | pIC50 | 106 | nM | IC50 | J Med Chem (2018) 61: 2027-2040 [PMID:29425443] |
| Reduced folate transporter 1/Folate transporter 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4833] [GtoPdb: 1014] [UniProtKB: P41440] | ||||||||
| GtoPdb | Inhibition of [3H]methotrexate uptake by CCRF-CEM (human T lymphoblast) cells. | - | 5.33 | pKi | 4700 | nM | Ki | J Med Chem (2004) 47: 6958-63 [PMID:15615544] |
| ChEMBL | Affinity towards RFC measured by the inhibition of [3H]MTX uptake | B | 5.46 | pKi | 3500 | nM | Ki | J Med Chem (2000) 43: 1910-1926 [PMID:10821704] |
| ChEMBL | Inhibition of RFC (unknown origin) expressed in Chinese hamster PC43-10 cells assessed as cell growth inhibition incubated up to 96 hrs by Celltiter-blue cell viability assay | B | 7.92 | pIC50 | 12 | nM | IC50 | J Med Chem (2014) 57: 8152-8166 [PMID:25234128] |
| ChEMBL | Binding affinity to human RFC expressed in Chinese hamster PC43-10 cells assessed as antiproliferative activity measured as reduction in cell viability after 96 hrs by Cell-Titer Blue assay | B | 7.92 | pIC50 | 12 | nM | IC50 | J Med Chem (2018) 61: 2027-2040 [PMID:29425443] |
| Folylpoly-gamma-glutamate synthetase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3171] [UniProtKB: Q05932] | ||||||||
| ChEMBL | Compound was evaluated for the inhibitory activity against Folyl-polyglutamate synthase from CCRF-CEM human leukemia cells. | B | 5.49 | pIC50 | 3200 | nM | IC50 | J Med Chem (1996) 39: 4340-4344 [PMID:8863812] |
| phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase/GAR transformylase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3972] [GtoPdb: 2612] [UniProtKB: P22102] | ||||||||
| ChEMBL | Inhibitory activity against GAR transformylase of Lactobacillus casei | B | 4.7 | pIC50 | >20000 | nM | IC50 | J Med Chem (1988) 31: 150-153 [PMID:3121855] |
| phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase/GAR transformylase in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3690] [GtoPdb: 2612] [UniProtKB: Q64737] | ||||||||
| ChEMBL | Inhibition of GAR transformylase from Lactobacillus casei | B | 4.7 | pIC50 | >20000 | nM | IC50 | J Med Chem (1988) 31: 2164-2169 [PMID:3184124] |
| ChEMBL | Inhibition of GAR transformylase from mammalian L1210 cells | B | 4.7 | pIC50 | >20000 | nM | IC50 | J Med Chem (1988) 31: 2164-2169 [PMID:3184124] |
| high mobility group box 1/High mobility group protein B1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2311236] [GtoPdb: 3279] [UniProtKB: P09429] | ||||||||
| ChEMBL | Binding affinity to N-terminal 6His-tagged HMGB1 AI region (1 to 87 residues) (unknown origin) expressed in Escherichia coli JM109 by SPR assay | B | 6.3 | pKd | 500 | nM | Kd | J Med Chem (2018) 61: 5093-5107 [PMID:29268019] |
| ChEMBL | Binding affinity to N-terminal 6His-tagged HMGB1 Bj region (88 to 181 residues) (unknown origin) expressed in Escherichia coli JM109 by SPR assay | B | 7.62 | pKd | 24 | nM | Kd | J Med Chem (2018) 61: 5093-5107 [PMID:29268019] |
| GtoPdb | Binding affinity to N-terminal 6His-tagged HMGB1 by SPR assay | - | 7.62 | pKd | 24 | nM | Kd | J Med Chem (2018) 61: 5093-5107 [PMID:29268019] |
| Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay | F | 7 | pIC50 | 100 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn and Cys59Arg or Ser108Asn and Asn51Ile double mutant by [3H]hypoxanthine incorporation assay | F | 7.07 | pIC50 | 84.89 | nM | IC50 | Antimicrob Agents Chemother (2009) 53: 3793-3798 [PMID:19528269] |
| ChEMBL | Antimalarial activity against Plasmodium falciparum Kenyan isolates by [3H]hypoxanthine incorporation assay | F | 7.08 | pIC50 | 83.6 | nM | IC50 | Antimicrob Agents Chemother (2009) 53: 3793-3798 [PMID:19528269] |
| ChEMBL | Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn, Asn51Ile and Cys59Arg triple mutant by [3H]hypoxanthine incorporation assay | F | 7.08 | pIC50 | 83.59 | nM | IC50 | Antimicrob Agents Chemother (2009) 53: 3793-3798 [PMID:19528269] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay | F | 7.1 | pIC50 | 79.43 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay | F | 7.1 | pIC50 | 79.43 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay | F | 7.1 | pIC50 | 79.43 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 by [3H]hypoxanthine incorporation assay | F | 7.2 | pIC50 | 63 | nM | IC50 | Antimicrob Agents Chemother (2009) 53: 3131-3134 [PMID:19364853] |
| ChEMBL | Antimalarial activity against Plasmodium falciparum isolate Kil-164 expressing DHFR Ser108Asn, Asn51Ile, Cys59Arg and Ile164Leu quadruple mutant by [3H]hypoxanthine incorporation assay | F | 7.25 | pIC50 | 56.63 | nM | IC50 | Antimicrob Agents Chemother (2009) 53: 3793-3798 [PMID:19528269] |
| ChEMBL | Antimalarial activity against pyrimethamine-sensitive Plasmodium falciparum 3D7 expressing wild type DHFR by [3H]hypoxanthine incorporation assay | F | 7.3 | pIC50 | 49.9 | nM | IC50 | Antimicrob Agents Chemother (2009) 53: 3793-3798 [PMID:19528269] |
| ChEMBL | Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum V1S expressing DHFR quadruple mutant with point mutations at codons 108, 51, 59 and 164 gene by [3H]hypoxanthine incorporation assay | F | 7.4 | pIC50 | 40 | nM | IC50 | Antimicrob Agents Chemother (2009) 53: 3793-3798 [PMID:19528269] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay | F | 7.4 | pIC50 | 39.81 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay | F | 7.5 | pIC50 | 31.62 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay | F | 7.5 | pIC50 | 31.62 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay | F | 9.96 | pIC50 | 0.11 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay | F | 10.05 | pIC50 | 0.09 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay | F | 10.15 | pIC50 | 0.07 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay | F | 10.15 | pIC50 | 0.07 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay | F | 10.4 | pIC50 | 0.04 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay | F | 10.4 | pIC50 | 0.04 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay | F | 10.4 | pIC50 | 0.04 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
| Proton-coupled folate transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795188] [GtoPdb: 1213] [UniProtKB: Q96NT5] | ||||||||
| ChEMBL | Binding affinity to human PCFT expressed in Chinese hamster R2/PCFT4 cells assessed as antiproliferative activity measured as reduction in cell viability after 96 hrs by Cell-Titer Blue assay | B | 6.92 | pIC50 | 121 | nM | IC50 | J Med Chem (2018) 61: 2027-2040 [PMID:29425443] |
| ChEMBL | Inhibition of PCFT (unknown origin) expressed in Chinese hamster R2/PCFT4 cells assessed as cell growth inhibition incubated up to 96 hrs by Celltiter-blue cell viability assay | B | 6.92 | pIC50 | 120.5 | nM | IC50 | J Med Chem (2014) 57: 8152-8166 [PMID:25234128] |
| Pteridine reductase 1 in Leishmania major (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6194] [UniProtKB: Q01782] | ||||||||
| ChEMBL | Inhibition of Leishmania major PTR1 by spectrophotometric assay | B | 6.74 | pKi | 180 | nM | Ki | J Med Chem (2012) 55: 8318-8329 [PMID:22946585] |
| ChEMBL | Inhibition of Leishmania major recombinant PTR1 | B | 7.41 | pKi | 39 | nM | Ki | J Med Chem (2010) 53: 221-229 [PMID:19916554] |
| Thymidylate synthase in Escherichia coli (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6137] [UniProtKB: C3SWJ7] | ||||||||
| ChEMBL | Inhibition of Escherichia coli thymidylate synthase | B | 4.05 | pIC50 | 90000 | nM | IC50 | J Med Chem (2005) 48: 7215-7222 [PMID:16279780] |
| ChEMBL | Inhibition of Escherichia coli thymidylate synthase | B | 4.05 | pIC50 | 90000 | nM | IC50 | J Med Chem (2008) 51: 4589-4600 [PMID:18605720] |
| ChEMBL | Inhibitory activity against Escherichia coli thymidylate synthase | B | 5.74 | pIC50 | 1800 | nM | IC50 | J Med Chem (2001) 44: 1993-2003 [PMID:11384244] |
| Thymidylate synthase in Lactobacillus casei (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5328] [UniProtKB: P00469] | ||||||||
| ChEMBL | Compound was evaluated for the inhibition of thymidylate synthase (TS) derived from Lactobacillus casei | B | 4 | pIC50 | 100000 | nM | IC50 | J Med Chem (1986) 29: 1786-1789 [PMID:3091834] |
| ChEMBL | Inhibition of Lactobacillus casei ATCC 7469 thymidylate synthase | B | 4 | pIC50 | 100000 | nM | IC50 | J Med Chem (1979) 22: 869-874 [PMID:109616] |
| ChEMBL | Inhibition of MTX-resistant Lactobacillus casei thymidylate synthetase | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (1977) 20: 1323-1327 [PMID:409842] |
| ChEMBL | Inhibitory activity against thymidylate synthase of Lactobacillus casei | B | 4.07 | pIC50 | 86000 | nM | IC50 | J Med Chem (1988) 31: 150-153 [PMID:3121855] |
| ChEMBL | In vitro inhibition of activity against Lactobacillus casei enzyme thymidylate synthase | F | 4.12 | pIC50 | 75000 | nM | IC50 | J Med Chem (1982) 25: 877-880 [PMID:7108907] |
| ChEMBL | Ability to inhibit Lactobacillus casei thymidylate synthase in vitro was determined | B | 4.4 | pIC50 | 40000 | nM | IC50 | J Med Chem (1980) 23: 899-903 [PMID:6772788] |
| thymidylate synthetase/Thymidylate synthase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1952] [GtoPdb: 2642] [UniProtKB: P04818] | ||||||||
| ChEMBL | Inhibition of human TS by spectrophotometric analysis | B | 6.22 | pKi | 600 | nM | Ki | J Med Chem (2012) 55: 8318-8329 [PMID:22946585] |
| ChEMBL | Inhibition of human thymidylate synthase | B | 4.54 | pIC50 | 29000 | nM | IC50 | J Med Chem (2005) 48: 7215-7222 [PMID:16279780] |
| ChEMBL | Inhibition of human thymidylate synthase | B | 4.54 | pIC50 | 29000 | nM | IC50 | J Med Chem (2008) 51: 4589-4600 [PMID:18605720] |
| ChEMBL | Inhibition of human thymidylate synthase at 30 degC under pH 7.4 by spectrophotometry | B | 4.54 | pIC50 | 29000 | nM | IC50 | Bioorg Med Chem (2010) 18: 953-961 [PMID:20056546] |
| ChEMBL | Inhibition of human TS assessed as oxidation of tetrahydrofolate to dihydrofolate after 2 to 12 mins by spectrophotometry | B | 4.74 | pIC50 | >18000 | nM | IC50 | Bioorg Med Chem (2011) 19: 3585-3594 [PMID:21550809] |
| ChEMBL | Inhibitory activity against human thymidylate synthase | B | 5.44 | pIC50 | 3600 | nM | IC50 | J Med Chem (2001) 44: 1993-2003 [PMID:11384244] |
| thymidylate synthetase/Thymidylate synthase in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3160] [GtoPdb: 2642] [UniProtKB: P07607] | ||||||||
| ChEMBL | Inhibitory activity against thymidylate synthase in murine tumor cells | B | 4.35 | pKi | 45000 | nM | Ki | J Med Chem (1982) 25: 518-522 [PMID:7086836] |
| ChEMBL | Inhibitory activity against thymidylate synthase isolated from L1210 leukemia cells | B | 4.7 | pIC50 | 20000 | nM | IC50 | J Med Chem (1988) 31: 449-454 [PMID:3339615] |
| ChEMBL | Inhibition of L1210 leukemia thymidylate synthase (TS) enzyme | B | 4.7 | pIC50 | 20000 | nM | IC50 | J Med Chem (1989) 32: 852-856 [PMID:2704031] |
| Thymidylate synthase (EC 2.1.1.45) (TS) (TSase) in Escherichia coli (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795153] [UniProtKB: E2QDN0] | ||||||||
| ChEMBL | Inhibition of Escherichia coli TS assessed as oxidation of tetrahydrofolate to dihydrofolate after 2 to 12 mins by spectrophotometry | B | 4.74 | pIC50 | >18000 | nM | IC50 | Bioorg Med Chem (2011) 19: 3585-3594 [PMID:21550809] |
| TLR4/Toll-like receptor 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5255] [GtoPdb: 1754] [UniProtKB: O00206] | ||||||||
| ChEMBL | Inhibition of TLR4 (unknown origin) by sandwich ELISA method | B | 5.98 | pIC50 | 1040 | nM | IC50 | Bioorg Med Chem Lett (2021) 49: 128315-128315 [PMID:34390826] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
